The stress hormone norepinephrine increases migration of prostate cancer cells in vitro and in vivo

International Journal of Oncology

Volumn 47, Issue 2, 2015, Pages 527-534

  Barbieri, Antonio ^a   Bimonte, Sabrina ^a   Palma, Giuseppe ^a   Luciano, Antonio ^a   Rea, Domenica ^a   Giudice, Aldo ^a   Scognamiglio, Giosuè ^a   La Mantia, Elvira ^a   Franco, Renato ^a   Perdonà, Sisto ^a   De Cobelli, Ottavio ^b   Ferro, Matteo ^b   Zappavigna, Silvia ^c   Stiuso, Paola ^c   Caraglia, Michele ^c   Arra, Claudio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Cell invasion; Cell migration; Epithelial mesenchymal transition; Metastases; Norepinephrine; Prostate cancer; Stress; adrenergic receptors

Indexed keywords

CYTOKERATIN; GELATINASE A; GELATINASE B; NORADRENALIN; PROPRANOLOL; UVOMORULIN; VIMENTIN; ADRA2B PROTEIN, HUMAN; ADRA2B PROTEIN, MOUSE; ALPHA 2 ADRENERGIC RECEPTOR; MMP2 PROTEIN, MOUSE; MMP9 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PREVENTION; CARCINOGENESIS; CELL MIGRATION; CHEMOPROPHYLAXIS; CHRONIC STRESS; COMPARATIVE STUDY; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INGUINAL LYMPH NODE; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER CELL LINE; TUMOR XENOGRAFT; ANIMAL; CELL MOTION; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; METASTASIS; PATHOLOGY; PROSTATIC NEOPLASMS; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN VITRO TECHNIQUES; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICE; NEOPLASM METASTASIS; NOREPINEPHRINE; PROPRANOLOL; PROSTATIC NEOPLASMS; RECEPTORS, ADRENERGIC, ALPHA-2; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84932620869     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2015.3038     Document Type: Article

References (36)

1. Lang K and Bastian P: Neurotransmitter effects on tumor cells and leukocytes. Prog Exp Tumor Res 39: 99-121, 2007.
2. Schuller HM: Neurotransmission and cancer: Implications for prevention and therapy. Anticancer Drugs 19: 655-671, 2008.
3. Liotta LA: An attractive force in metastasis. Nature 410: 24-25, 2001.
4. Entschladen F, Drell TL IV, Lang K, Joseph J and Zaenker KS: Tumour-cell migration, invasion, and metastasis: Navigation by neurotransmitters. Lancet Oncol 5: 254-258, 2004.
5. Entschladen F, Lang K, Drell TL, Joseph J and Zaenker KS: Neurotransmitters are regulators for the migration of tumor cells and leukocytes. Cancer Immunol Immunother 51: 467-482, 2002.
6. Palm D, Lang K, Niggemann B, Drell TL IV, Masur K, Zaenker KS and Entschladen F: The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers. Int J Cancer 118: 2744-2749, 2006.
7. Drell TL IV, Joseph J, Lang K, Niggemann B, Zaenker KS and Entschladen F: Effects of neurotransmitters on the chemokinesis and chemotaxis of MDA-MB-468 human breast carcinoma cells. Breast Cancer Res Treat 80: 63-70, 2003.
8. Masur K, Niggemann B, Zanker KS and Entschladen F: Norepinephrine-induced migration of SW 480 colon carcinoma cells is inhibited by beta-blockers. Cancer Res 61: 2866-2869, 2001.
9. Lang SH, Hyde C, Reid IN, Hitchcock IS, Hart CA, Bryden AA, Villette JM, Stower MJ and Maitland NJ: Enhanced expression of vimentin in motile prostate cell lines and in poorly differentiated and metastatic prostate carcinoma. Prostate 52: 253-263, 2002.
10. Shan T, Cui X, Li W, Lin W, Li Y, Chen X and Wu T: Novel regulatory program for norepinephrine-induced epithelialmesenchymal transition in gastric adenocarcinoma cell lines. Cancer Sci 105: 847-856, 2014.
11. Shakhar G and Ben-Eliyahu S: In vivo -adrenergic stimulation suppresses natural killer activity and compromises resistance to tumor metastasis in rats. J Immunol 160: 3251-3258, 1998.
12. Reiche EM, Nunes SO and Morimoto HK: Stress, depression, the immune system, and cancer. Lancet Oncol 5: 617-625, 2004.
13. Barbieri A, Palma G, Rosati A, Giudice A, Falco A, Petrillo A, Petrillo M, Bimonte S, Di Benedetto M, Esposito G, et al: Role of endothelial nitric oxide synthase (eNOS) in chronic stresspromoted tumour growth. J Cell Mol Med 16: 920-926, 2012.
14. Moreno-Smith M, Lutgendorf SK and Sood AK: Impact of stress on cancer metastasis. Future Oncol 6: 1863-1881, 2010.
15. Feng Z, Liu L, Zhang C, Zheng T, Wang J, Lin M, Zhao Y, Wang X, Levine AJ and Hu W: Chronic restraint stress attenuates p53 function and promotes tumorigenesis. Proc Natl Acad Sci USA 109: 7013-7018, 2012.
16. Moretti S, Massi D, Farini V, Baroni G, Parri M, Innocenti S, Cecchi R and Chiarugi P: -adrenoceptors are upregulated in human melanoma and their activation releases pro-tumorigenic cytokines and metalloproteases in melanoma cell lines. Lab Invest 93: 279-290, 2013.
17. Lang K, Drell TL, Niggemann B, Zänker KS and Entschladen F: Neurotransmitters regulate the migration and cytotoxicity in natural killer cells. Immunol Lett 90: 165-172, 2003.
18. Lang K, Drell TL IV, Lindecke A, Niggemann B, Kaltschmidt C, Zaenker KS and Entschladen F: Induction of a metastatogenic tumor cell type by neurotransmitters and its pharmacological inhibition by established drugs. Int J Cancer 112: 231-238, 2004.
19. Zhang D, Ma Q, Shen S and Hu H: Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: The study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell. Pancreas 38: 94-100, 2009.
20. Paredes A, Gálvez A, Leyton V, Aravena G, Fiedler JL, Bustamante D and Lara HE: Stress promotes development of ovarian cysts in rats: The possible role of sympathetic nerve activation. Endocrine 8: 309-315, 1998.
21. Liotta LA and Kohn EC: The microenvironment of the tumourhost interface. Nature 411: 375-379, 2001.
22. Lutgendorf SK, Sood AK and Antoni MH: Host factors and cancer progression: Biobehavioral signaling pathways and interventions. J Clin Oncol 28: 4094-4099, 2010.
23. V ilardi BM, Bravo-Calderón DM, Bernabé DG, Oliveira SH and Oliveira DT: VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors. Tumour Biol 34: 139-143, 2013.
24. Flint MS, Baum A, Episcopo B, Knickelbein KZ, Liegey Dougall AJ, Chambers WH and Jenkins FJ: Chronic exposure to stress hormones promotes transformation and tumorigenicity of 3T3 mouse fibroblasts. Stress 16: 114-121, 2013.
25. Newton PK, Mason J, Bethel K, Bazhenova L, Nieva J, Norton L and Kuhn P: Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res 73: 2760-2769, 2013.
26. H ara MR, Kovacs JJ, Whalen EJ, Rajagopal S, Strachan RT, Grant W, Towers AJ, Williams B, Lam CM, Xiao K, et al: A stress response pathway regulates DNA damage through 2-adrenoreceptors and -arrestin-1. Nature 477: 349-353, 2011.
27. Entschladen F, Palm D, Lang K, Drell TL IV and Zaenker KS: Neoneurogenesis: Tumors may initiate their own innervation by the release of neurotrophic factors in analogy to lymphangiogenesis and neoangiogenesis. Med Hypotheses 67: 33-35, 2006.
28. Felten DL: Direct innervation of lymphoid organs: Substrate for neurotransmitter signaling of cells of the immune system. Neuropsychobiology 28: 110-112, 1993.
29. Muller WA: Regulate globally, act locally: adrenergic nerves promote leukocyte recruitment. Immunity 37: 189-191, 2012.
30. Sokoowska P and Nowak JZ: Constitutive activity of beta-adrenergic receptors in C6 glioma cells. Pharmacol Rep 57: 659-663, 2005.
31. Sloan EK, Priceman SJ, Cox BF, Yu S, Pimentel MA, Tangkanangnukul V, Arevalo JM, Morizono K, Karanikolas BD, Wu L, et al: The sympathetic nervous system induces a metastatic switch in primary breast cancer. Cancer Res 70: 7042-7052, 2010.
32. Armaiz-Pena GN, Cole SW, Lutgendorf SK and Sood AK: Neuroendocrine influences on cancer progression. Brain Behav Immun 30 (Suppl): S19-S25, 2013.
33. Cole SW and Sood AK: Molecular pathways: Beta-adrenergic signaling in cancer. Clin Cancer Res 18: 1201-1206, 2012.
34. H assan S, Karpova Y, Baiz D, Yancey D, Pullikuth A, Flores A, Register T, Cline JM, D'Agostino R Jr, Danial N, et al: Behavioral stress accelerates prostate cancer development in mice. J Clin Invest 123: 874-886, 2013.
35. Yang EV and Eubank TD: The impact of adrenergic signaling in skin cancer progression: Possible repurposing of -blockers for treatment of skin cancer. Cancer Biomark 13: 155-160, 2013.
36. Sood AK and Lutgendorf SK: Stress influences on anoikis (Review). Cancer Prev Res (Phila) 4: 481-485, 2011.